Leaders and experts
Optum patient insights is home to many highly trained, multidiscipline scientists and consultants. Collectively, our experts have decades of experience researching, studying and developing patient-reported outcomes.
VP, Patient Insights and Principal Scientist
Martha Bayliss has more than 20 years of experience working with patient-reported outcomes (PROs). Her expertise includes the development, validation and application of numerous generic and disease-specific health surveys.
She applies qualitative and quantitative measurement methods in the development, customization and implementation of PROs. These surveys are used in clinical trials, program evaluation studies, promotional initiatives and for many other purposes across the health care spectrum.
Bayliss frequently consults with pharmaceutical companies on PRO strategy, applying state-of-the art methods required by regulatory agencies for clinical trial endpoints in early and late-phase studies.
Jakob Bue Bjørner, MD, PhD
Chief Science Officer, Patient Insights
Dr. Jakob Bjørner specializes in applying modern psychometric theory to the measurement of health outcomes. He has been an International Quality of Life Assessment (IQOLA) project collaborator for more than 10 years and was a consultant before joining the company in 2003.
Formerly a professor at the Danish National Institute of Occupational Health, Dr. Bjørner co-developed the Optum® Dynamic Health Assessment (DYNHA®) system. He has also created numerous computerized adaptive health assessments of generic and disease-specific health outcomes.
An MD by training, Dr. Bjørner also has a PhD in medical sociology from the University of Copenhagen. He is an award recipient for his research on quality of life and HIV.
Vice President, Senior Scientist
Mark Kosinski has more than 20 years of experience in developing and analyzing patient-reported outcome (PRO) measures. He participated in the development and validation of the SF-36®, SF-12® and the SF-8™ Health Surveys.
He assisted with the development and validation of the Asthma Control Test™ (ACT™), the Headache Impact Test™ (HIT-6™) and other industry-sponsored PRO measures. Kosinski participated in the development and analysis of item banks for computerized adaptive health assessments.
Kosinski has co-authored more than 160 peer-reviewed journal articles related to the development and analysis of PRO measures used in clinical research, randomized controlled trials and population health initiatives.
He has contributed to the writing of 10 manuals and interpretation guides for various PRO measures including the SF-36, SF-12 and SF-8.
Over the past 15 years, he has actively worked with the pharmaceutical industry in the analysis of clinical trial data with PRO measures as secondary indicators of treatment efficacy.
Kosinski received his Master of Arts in Psychology from Bridgewater State University.
Vice President of Technology, Patient Insights
Robert Frick has more than 20 years of experience in software technology and engineering management. His expertise also includes 14 years of medical device development with Collins Medical.
His most recent experience includes director of product development for GE, vice president of engineering at Intellution, and director of research and development at Federal Products.
Frick began his career as an engineer with Northrop and received his Bachelor of Science in Computer Engineering from Boston University.
Michelle K. White, PhD
VP, Outcomes Insight Consulting and Senior Scientist
Dr. Michelle White is a member of the Optum team specializing in health-related quality of life patient-reported outcomes. Dr. White has conducted numerous qualitative studies and quantitative studies, and has co-authored several survey instrument manuals.
Her recent projects include:
- Modifying and validating a daily diary to predict off-time in patients with Parkinson’s disease
- Conducting a large, multi-site, observational study in alcohol-dependent individuals
- Validating a cognitive deficit survey in a depressed population
- Evaluating a health education toolkit designed to improve adherence in diabetes patients
Dr. White's expertise includes a decade conducting addiction treatment outcome studies, and helping to develop and implement surveys for addiction and mental health treatment.
She has published work related to multiple grants for the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA). She oversaw the implementation of the Global Appraisal of Individual Needs (GAIN) bio-psychosocial assessment across 14 states and dozens of individual treatment providers.
Dr. White has provided research training on selecting and designing assessment programs and quality assurance of assessment data. Additionally, she has provided clinical training on using assessment data for diagnoses, treatment placement decisions and treatment planning.
She has worked with individuals with behavioral disorders in residential treatment centers, detention centers and other behavioral health settings.
Dr. White has held adjunct positions at Illinois State University and the University of Illinois, where she received her Master of Science and PhD in Sociology, respectively.